ListarArtículos (Medicina) por materia "NAFLD"
Mostrando ítems 1-19 de 19
-
Artículo
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
(Frontiers Media, 2021-11-24)Metabolic associated fatty liver disease (MAFLD) is the most prevalent form of liver disease worldwide, accounting for a ...
-
Artículo
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
(OXFORD UNIV PRESS, 2022)Metabolic associated fatty liver disease (MAFLD) is the most prevalent form of liver disease worldwide, accounting for a ...
-
Artículo
Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
(Lippincott, Williams & Wilkins, 2020)The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) presents many ...
-
Artículo
Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
(MDPI AG, 2018-03-19)Genetics and epigenetics play a key role in the development of several diseases, including nonalcoholic fatty liver disease ...
-
Artículo
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
(Aran Ediciones S.A., 2019)Background: recent evidence suggests a causal link between serum uric acid and the metabolic syndrome, dia betes me ...
-
Artículo
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
(MDPI AG, 2022)Abstract: A common splice variant in HSD17B13 (rs72613567:TA) was recently found to be associated with a reduced risk of ...
-
Artículo
Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model
(MDPI, 2021)Our aim was to analyze whether depressive symptoms mediated the association between physical quality of life (QoL) and ...
-
Artículo
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
(Elsevier, 2022)Background & Aims: Autophagy-related gene 3 (ATG3) is an enzyme mainly known for its actions in the LC3 lipidation pro ...
-
Artículo
Management of NAFLD patients with advanced fibrosis
(Wiley-Blackwell, 2021-06-21)The prevalence of non alcoholic fatty liver disease (NAFLD) has increased to 25% in the general population and could double ...
-
Artículo
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
(Aran Ediciones S.A., 2019)Introduction: non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed world. ...
-
Artículo
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
(Willey, 2022)Background and Aims We previously identified subsets of patients with NAFLD with different metabolic phenotypes. Here ...
-
Artículo
Obesity dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
(2012)Our understanding of the mechanisms by which nonalcoholic fatty liver disease (NAFLD) progresses from simple steatosis to ...
-
Artículo
Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and Obesity
(MDPI, 2021)Our aim was to analyze how type 2 diabetes and obesity influence quality of life (QoL) and coping in patients with ...
-
Artículo
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD
(Wiley, 2023)Background and Aims Extracellular vesicles (EVs) have emerged as a potential source of circulating biomarkers in liver ...
-
Artículo
Stratification of patients in NASH clinical trials: a pitfall for trial success
(Elsevier, 2020)Identifying the most effective therapeutic intervention in patients with NAFLD is challenging. Precise stratification in ...
-
Artículo
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
(SPRINGER, 2022)Background NAFLD clinical trials have shown suboptimal results, particularly for liver fibrosis, despite the robust ...
-
Artículo
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
(Elsevier, 2021-12)Background Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of ...
-
Artículo
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
(Elsevier, 2020)Non-Alcoholic Fatty Liver Disease (NAFLD), a progressive liver disease that is closely associated with obesity, type 2 ...
-
Artículo
Vitality, mental health and role-physical mediate the influence of coping on depressive symptoms and self-efficacy in patients with non-alcoholic fatty liver disease: a cross-sectional study
(Elsevier, 2022)Objective: Our aim was to determine whether the association between active coping and depressive symptoms in patients ...